Genetic Technologies Ltd.
GENE
GENE was delisted on the 16th of October, 2024.
11 hedge funds and large institutions have $130K invested in Genetic Technologies Ltd. in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 4 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
8% less funds holding
Funds holding: 12 → 11 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
39% less capital invested
Capital invested by funds: $212K → $130K (-$82.3K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$18.5K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$4.59K |
| 3 |
VF
Virtu Financial
New York
|
+$2.29K |
| 4 |
GI
Gradient Investments
Arden Hills,
Minnesota
|
+$2.17K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$441 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OMC
Old Mission Capital
Chicago,
Illinois
|
-$25.1K |
| 2 |
CA
Cetera Advisors
Denver,
Colorado
|
-$16.2K |
| 3 |
Morgan Stanley
New York
|
-$13.6K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$3.52K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.41K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $73.4K | -$13.6K | -2,745 | -13% |
|
|
2
RhumbLine Advisers
Boston,
Massachusetts
| $15.6K | +$18.5K | +3,740 | New |
|
|
VF
3
Virtu Financial
New York
| $15K | +$2.29K | +463 | +15% |
|
|
TSS
4
Two Sigma Securities
New York
| $12.4K | +$4.59K | +926 | +45% |
|
|
SA
5
Scarborough Advisors
Annapolis,
Maryland
| $8.84K | – | – | – |
|
|
GI
6
Gradient Investments
Arden Hills,
Minnesota
| $1.82K | +$2.17K | +438 | New |
|
|
FDCDDQ
7
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $1.66K | – | – | – |
|
8
Wells Fargo
San Francisco,
California
| $831 | – | – | – |
|
|
9
UBS Group
Zurich,
Switzerland
| $83 | -$3.52K | -710 | -97% |
|
|
NC
10
NewSquare Capital
Newtown Square,
Pennsylvania
| $83 | +$99 | +20 | New |
|
|
OMC
11
Old Mission Capital
Chicago,
Illinois
| – | -$25.1K | -4,322 | Closed |
|
|
CA
12
Cetera Advisors
Denver,
Colorado
| – | -$16.2K | -2,792 | Closed |
|
|
13
Citadel Advisors
Miami,
Florida
| – | -$1.41K | -242 | Closed |
|
|
14
Simplex Trading
Chicago,
Illinois
| – | +$441 | +89 | +212% |
|
GENE Hedge Fund Activity: Q2 2023 in Review
11 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Genetic Technologies Ltd. (GENE) for Q2 2023, worth a combined $130K — down 39% from $212K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of GENE and 3 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 3 added.
The largest buyer was RhumbLine Advisers, opening a new position worth an estimated $18.5K. The largest seller was Old Mission Capital, exiting entirely with an estimated $25.1K sold.
- 11 institutional investors held Genetic Technologies Ltd. (GENE) as of Q2 2023, down from 12 in Q1 2023.
- Funds reported $130K of Genetic Technologies Ltd. stock for Q2 2023, down 39% quarter-over-quarter.
- 3 funds opened new Genetic Technologies Ltd. positions in Q2 2023 and 4 closed out, a net change of -1 holder.
- The largest Genetic Technologies Ltd. buyer in Q2 2023 was RhumbLine Advisers, an estimated $18.5K added.
- The largest Genetic Technologies Ltd. seller in Q2 2023 was Old Mission Capital, an estimated $25.1K sold.
Based on aggregated 13F filings for Q2 2023.